par Pérez-López, Faustino R;Delvoye, Pierre 
;Denayer, Pierre ;L'Hermite, Marc ;Roncero, M.C.;Robyn, Claude
Référence Acta endocrinologica (Print ed.), 79, 4, page (644-657)
Publication Publié, 1975
;Denayer, Pierre ;L'Hermite, Marc ;Roncero, M.C.;Robyn, Claude Référence Acta endocrinologica (Print ed.), 79, 4, page (644-657)
Publication Publié, 1975
Article révisé par les pairs
| Résumé : | Intramuscular injection of 0.2 methylergobasine maleate (Methergin, Sandoz) in women on day 3 post partum, in regularly menstruating women and in adult men, is followed within 30 to 75 min by a 50% decrease in serum prolactin concentration: the levels remain low until 180 min and increase between 180 and 240 min. The amplitude of the decrease is the same when prolactin is measured in terms of the same serum prolactin standard by a homologous ovine assay and by a homologous human assay. However, in the case of regularly menstruating women and of men serum prolactin concentration is some three times higher when estimated by the ovine assay than when estimated by the human assay. This difference between assay results obtained by the two radioimmunoassay methods could be due to heterogeneity of serum prolactin. However, non specific effects of serum are not excluded. In regularly menstruating women and in men, intramuscular injection of 0.2 mg methylergobasine maleate is followed within 45 to 75 min by a 50% decrease in immunoreactive serum LH concentration without concomitant change in immunoreactive FSH. The depression of LH secretion lasts for 1 to 2 h. The circulating levels of HCG in post partum women are not modified after intramuscular injection of Methergin. In humans as in animals and in in vitro studies, inhibition of prolactin and LH release induced by ergot drugs are likely due to both an indirect effect via the hypothalamus and to a direct effect on the pituitary cells. |
